Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT
Evaxion Biotech A/S Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Nov 14, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.58M | -3.63M | -1.94M | -6.2M | 1.19M | -4.52M | -5.68M | -5.68M | -6.24M | -6.87M | -5.74M | -4.77M | -5.79M | -8.37M | -5.25M | -6.82M | -4.09M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 115K | 200K | n/a | n/a | 571K | n/a | n/a | n/a | 344K | n/a | n/a | n/a |
Stock-Based Compensation | n/a | 357K | n/a | n/a | n/a | -21K | 100K | n/a | n/a | -58K | 300K | n/a | n/a | 79K | 600K | 400K | n/a |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | 197K | -93K | n/a | n/a | 1.95M | -1.9M | 428.1K | -2.17M | 1.84M | -906K | -738K | 1.04M |
Other Non-Cash Items | 1.58M | 3.27M | 1.94M | 6.2M | -1.19M | 1.52M | 281K | 5.68M | 6.24M | 63K | -326K | -849K | -226K | 2.41M | -139K | 69K | -980K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | 904K | 707K | n/a | n/a | 465K | -801K | 427K | -2.17M | 1.84M | -906K | -738K | 1.04M |
Operating Cash Flow | n/a | n/a | n/a | n/a | n/a | -2.01M | -4.39M | n/a | n/a | -5.83M | -6.57M | -5.19M | -8.19M | -4.12M | -6.29M | -7.49M | -4.04M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 1K | -65K | n/a | n/a | 61K | -89K | -83K | -181K | -176K | -332K | -510K | -342K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.95K | -931.7 | 30.88K | -14.96K | 14.96K |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | 1K | 6K | 22K | -1K | 1K | 15K | -45K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | 1K | -65K | n/a | n/a | 56K | -88K | -77K | -159K | -177K | -331K | -495K | -327K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -107K | 7.74M | -144K | -67K | -35K | -43K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 5.26M | 96K | n/a | n/a | 546K | -131K | -221K | n/a | -1.16M | 1K | n/a | -2.6M |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | 5.26M | 96K | n/a | n/a | 546K | -131K | -300K | 7.74M | 24.65M | -65K | -35K | 25.25M |
Net Cash Flow | n/a | n/a | n/a | n/a | n/a | 2.98M | -4.51M | -3.12M | -2.94M | -4.67M | -7.4M | -6.16M | -757K | 20.22M | -6.86M | -8.16M | 21.12M |
Free Cash Flow | n/a | n/a | n/a | n/a | n/a | -2.01M | -4.46M | n/a | n/a | -5.77M | -6.66M | -5.27M | -8.37M | -4.29M | -6.63M | -8M | -4.38M |